Pfizer Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FINANCIAL -- Pfizer Inc. on November 14 announced that Albert Bourla has been named Chief Operating Officer effective January 1, 2018. The FINANCIAL -- Pfizer Inc. on November 14 announced that Albert Bourla has been named Chief Operating Officer effective January 1, 2018. "The naming of a Chief Operating Officer comes at a time when our business is strong as we continue to advance our strategy while also managing a dynamic and challenging external environment, said » The FINANCIAL Pharmacy

Press release content from Business Wire. The AP news staff was not involved in its creation.

The best uncensored news, information, and analysis.

Pfizer aims to fund the deal with cash on hand once all regulatory approvals have been obtained.

Pfizer plans to acquire Utah-based Arena Pharmaceuticals for $6.7 billion. Arena Pharmaceuticals is a clinical stage company that develops immunotherapies to treat inflammatory diseases.